GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...

Discover how pharmaceutical industry-funded drug trials are creating jobs and driving economic growth in the Buckeye State.

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...

French food ingredient maker Roquette reported a sharp drop in core profit in 2024 on Friday, citing weaker sales in its main ingredients market, but good performance in its pharmaceutical activities ...

Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed ...

The head of a representative body for Ireland’s pharma industry is confident that the 50,000-strong workforce in the country will still be here in five years, despite US president Donald Trump ...

New Delhi: Competition Commission of India (CCI) has approved the proposed combination involving acquisition of pharma solution segment and product lines of Nourish segment of International Flavors & ...

Aveo Pharmaceuticals asserts that a stop-production notice was issued due to non-compliance with GMP standards, not for exporting opioid-based drugs. They have taken corrective measures and are ...

Botanix Pharmaceuticals (ASX:BOT) says it is off to a bright start with US sales of its drug to treat excessive underarm sweating well beyond what’s needed to regulate body temperature. The ...